TNF and inflammatory bowel disease: Etanercept, a recombinant DNA-derived compound derived from the human immunoglobulin G1 and a TNFα antagonist, is a commonly used treatment for SpA, although it may induce paradoxical gastrointestinal inflammation and should therefore be avoided in the IBD population [91].